Traduction de «format d'essai » (Français → Anglais) :

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and treatment being ensured across sites; (e) who is performing the diagnoses for CCSVI for each site, (i) ho ...[+++]w is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...

(Return tabled) Question No. 1123 Ms. Kirsty Duncan: With respect to the government’s position on chronic cerebrospinal venous insufficiency (CCSVI): (a) does the government track clinical trials on CCSVI currently being undertaken by other countries and, if yes, what are all clinical trials, identified by phase, currently being undertaken worldwide, (i) which countries are undertaking Phase lll trials; (b) does the government question whether CCSVI exists and, if yes, (i) why does the government not question whether treating CCSVI actually improves quality of life for Canadians with multiple sclerosis (MS); (c) how many cases of " major complications associated with venous angioplasty" have occurred in Canada and, if it is not possible ...[+++]to give this number, why, (i) what are identified complications to CCSVI and, for each complication, how many cases versus the number of procedures undertaken have occurred; (d) what are all procedures that have been performed on veins in Canada, including, procedures for Budd-Chiari syndrome and May-Thurner syndrome; (e) what is the government's position on ballooning veins and why does it consider that ballooning veins even once could be unsafe on fragile veins, even though participants involved in the proposed clinical trial will experience two procedures-one real, one simulated-in a one-year period; (f) is the government consulting with Canadians with MS, if so, (i) provide a list of all CCSVI groups the Minister of Health has met with along with the dates of the meetings, (ii) provide a list of all MS groups the Minister of Health has met with along with the dates of the meetings, (iii) provide the number of Canadians with MS the Minister of Health has met and the dates of all meetings, and if the government is not consulting, (iv) why not; (g) how does inviting the investigators of the seven MS-funded CCSVI studies to participate in the consensus workshop on ultrasound imaging meet CIHR's conflict of interest g ...

26. Fourth, concerning ‘role and task sharing’, considers that positive examples exist in initiatives such as the French-Belgian cooperation in fighter pilot training, the UK-French agreement on the sharing of aircraft carriers, the French-German initiative on helicopter pilot training, or the Belgian-Dutch navy cooperation, where a number of national support structures are shared with the partner; highlights especially the opportunities in the area of education, training and exercises, and especially in sharing military academies, test and evaluation facilities and facilities for pilot training; in the case of some niche capabilities, ...[+++] considers role- and task-sharing the only viable way for most Member States to ensure access to some rare capabilities such as CBRN units or hospital aircraft;

26. Fourth, concerning ‘role and task sharing’, considers that positive examples exist in initiatives such as the French-Belgian cooperation in fighter pilot training, the UK-French agreement on the sharing of aircraft carriers, the French-German initiative on helicopter pilot training, or the Belgian-Dutch navy cooperation, where a number of national support structures are shared with the partner; highlights especially the opportunities in the area of education, training and exercises, and especially in sharing military academies, test and evaluation facilities and facilities for pilot training; in the case of some niche capabilities, ...[+++] considers role- and task-sharing the only viable way for most Member States to ensure access to some rare capabilities such as CBRN units or hospital aircraft;

For training, technological development or work practices, for example, we have a Canada-wide training organization that is trying to standardize training all across Canada.

To rationalise and streamline, in accordance with the Joint Interim Report, the education and training processes at European level by bringing the priorities of the above conclusions and the Copenhagen process groups within the framework of the Education and Training 2010 work programme. To prepare and examine proposals for a European Qualifications Framework and a European Credit Transfer System for VET. To develop a coherent approach and closer cooperation, both at national and European level, with: Higher Education, including developments under the Bologna process European Economic, Employment, sustainable development and Social Inclusion Policies (for example in relation to National Action Plans) and between research, practice and polic ...[+++]y by networking and exchange of innovation and good examples of policy and practice. To provide information on progress made and future actions for development of VET involving all relevant stakeholders, at national level as part of the integrated biennial report on "Education and Training 2010", in the context of implementing national lifelong learning strategies. To develop closer links with key partners, including the social partners at European, national, regional and sectoral levels, taking into account the social partners' "Framework of actions for the lifelong development of competencies and qualifications" . To use fully the current Leonardo da Vinci programme and the future integrated action programme in the field of lifelong learning to support the development, testing, and implementation of innovative actions to advance VET reform".